SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

CFRA Maintains Hold on Mednax, Lowers Price Target to $15

CFRA analyst Paige Meyer maintains Mednax (NYSE:MD) with a Hold and lowers the price target from $22 to $15.

Benzinga · 05/11/2020 16:47

CFRA analyst Paige Meyer maintains Mednax (NYSE:MD) with a Hold and lowers the price target from $22 to $15.